Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Capital Expenditures (2020 - 2025)

Candel Therapeutics' Capital Expenditures history spans 4 years, with the latest figure at $47000.0 for Q4 2023.

  • On a quarterly basis, Capital Expenditures rose 124.48% to $47000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $457000.0, a 562.32% increase, with the full-year FY2025 number at $132000.0, up 725.0% from a year prior.
  • Capital Expenditures hit $47000.0 in Q4 2023 for Candel Therapeutics, down from $103000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for CADL hit a ceiling of $1.8 million in Q1 2021 and a floor of -$911000.0 in Q2 2021.
  • Historically, Capital Expenditures has averaged $252857.1 across 4 years, with a median of $172000.0 in 2023.
  • Biggest five-year swings in Capital Expenditures: surged 271.93% in 2021 and later tumbled 239.03% in 2022.
  • Tracing CADL's Capital Expenditures over 4 years: stood at $1.4 million in 2020, then plummeted by 64.18% to $504000.0 in 2021, then tumbled by 138.1% to -$192000.0 in 2022, then surged by 124.48% to $47000.0 in 2023.
  • Business Quant data shows Capital Expenditures for CADL at $47000.0 in Q4 2023, $103000.0 in Q3 2023, and $241000.0 in Q2 2023.